BIBP-3226
N/A
Report date: 2025/06/11 20:01:15
NME
Base Information
Drug NameBIBP-3226
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDr Karl Thomae Gmbh
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim International Gmbh
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A